GildGets a daily close above 70.69 could be breaking out of a big wedge. Keep eyes on this for a potential big move. Keep stops tight below 68
GIS trade ideas
GILDIf it holds the level, you can consider buying approximately, roughly speaking, from 71 .
7/30/21 RBC Capital Maintains Outperform 84.0
7/30/21 SVB Leerink Maintains Outperform 77.0
4/30/21 SVB Leerink Maintains Outperform 74.0
Gilead - Another capital preservation candidateLooks like the base is formed and a reversal is on track. Target 1&2 - Dotted lines.
The longer the base ...Trend(OBV) uses True Strength Index to analyze "On-Balance-Volume", which measures buying and selling pressure as a cumulative indicator.
The Trend(OBV) crossed above its signaling Bollinger Band. This is a sign of bullish character. In addition, both Bollinger band and Donchian channel of the Trend(OBV) display squeezes.
Can GILD break out and rally from the current base?
GILD: Triangle Within A Triangle Plus VolumeFUNDAMENTALS:
GILD ( Gilead Sciences ) is that company that found the cure for hepatitis C. The fundamentals are improving again. The industry has not done as well as in others. However, with the recent acquisition of MYR Pharmaceuticals (myr-pharma.com), GILD is currently in phase 3 for the treatment of hepatitis B and D.
***Revenue is also generated when more people catch and/or are dying of covid with their covid treatment called Veklury. Revenue soared around $1.5 billion from Veklury alone.
Target 80 or 165
$GILD - Triangle viewpointMain resistance 69.5 (Alarm set for breaking and stabilizing above).
I do not recommend buying or sell GILD stocks.
Gilead GILD w24 2021. Short to 63Weekly
Consolidation
Daily
Below SR level
Also I expect sellers pressure from those who buy it in 2020 but didnt get profit.
Short
Open 66
TP 63
SL
68
RR 2,17
GILD: Breakout Confirmed, 11.19% Potential Profit!Description: GILD is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position.
Stats:
1. Ideal buy range: $66.7 - $68.7
2. Take profit: $75.29
3. Stop Loss: $65.68
4. Risk To Reward: 1 / 4
5. Accuracy Rating: 83%
IRON TARIHi guys,
IV keeps quite low, this week too, so I have to reverse my Tari condor.
3 weeks 6% strike, 37% of probability to end ITM. So I reverse the condor, so the odds come to my side, because I have 63% of probability to gain a profit, and my RR is almost 1:1 ( 0.85 commisions incl.)
So subscribe for free to trade with Tari Condor!
Enjoy your wallet!
Tari
$GILD - two screeners say to enterWatching this one. I have two screeners suggesting it plus its between two volume shelves.
GILD: Breakout Confirmed, 13.54% Potential Profit!Description: GILD is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position.
Stats:
1. Ideal buy range: $67.1 - $69.1
2. Take profit: $76.62
3. Stop Loss: $65.46
4. Risk To Reward: 1 / 5
5. Accuracy Rating: 83%
$GILD Gilead Sciences No Trade Zone
Gilead is once again stuck within a congestion channel and makes it not worthy of a trade into earnings.
Alerts are set for a break from this channel for a short or long opportunity in the future.
$GILD Gilead Breaks above the 200MA
The stock has finally shown some signs of a longer term reversal.
-Volume impressive
-Golden cross imminent
-Indicators bullish.
Potential long above $66.66
GILD Long Wedge Breakout
one swing crossed SMA50 and SMA200
Entry 66.3
Stop 63
Target 72
I am not a PRO trader. I trade option to test my trading plan with small cost.
The max Risk of each plan is less than 1% of my account.
If you like this idea, please use SIM/Demo account to try it.
$GILD with a Neutral outlook following its earnings #Stocks The PEAD projected a Neutral outlook for $GILD after a Negative Under reaction following its earnings release placing the stock in drift A
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
GILD Scienced - GILD: Hepatitis Cures for C, B and DFUNDAMENTALS:
GILD (Gilead Sciences) is that company that found the cure for hepatitis C. The fundamentals are improving again. The industry has not done as well as in others. However, with the recent acquisition of MYR Pharmaceuticals (myr-pharma.com), GILD is currently in phase 3 for the treatment of hepatitis B and D.
TECHNICALS:
Monthly:
wedge pattern and volume divergence tells of that institutions and investors may begin to sponsor this company again.
MACD divergence
Weekly:
regular divergence confirms the case for the monthly pattern
breach to new minor highs within a larger pattern
positive MACD development
volume support
Daily:
Crown pattern
Volume confirmation
Daily horizontal support
Daily wedge pattern being tested and broken
